Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating activities
Net income	$ 163,880	$ 81,157
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	78,606	63,833
Amortization of deferred financing costs and debt discount	3,817	3,210
Straight-line rent revenue and other	(65,333)	(47,846)
Share / (Unit)-based compensation expense	12,264	10,036
Gain from sale of real estate	(989)	(1,325)
Impairment charges		19,006
Straight-line rent and other (recovery) write-off	(5,238)	7,717
Debt refinancing and unutilized financing costs	2,269	611
Pre-acquisition rent collected - Circle Transaction		(35,020)
Other adjustments	(3,575)	(421)
Changes in:
Interest and rent receivables	13,396	2,137
Accounts payable and accrued expenses	5,062	(4,221)
Deferred revenue	(15,429)	8,040
Net cash provided by operating activities	188,730	106,914
Investing activities
Cash paid for acquisitions and other related investments	(1,778,417)	(1,973,661)
Net proceeds from sale of real estate	10,905	9,597
Principal received on loans receivable	40,937
Investment in loans receivable	(23,935)	(2,307)
Return of equity investment	11,000	63,122
Capital additions and other investments, net	(42,050)	8,460
Net cash used for investing activities	(1,781,560)	(1,894,789)
Financing activities
Proceeds from term debt, net of discount	1,839,735	915,950
Payments of term debt	(689,450)
Revolving credit facilities, net	8,910
Dividends / Distribution paid	(147,666)	(138,074)
Lease deposits and other obligations to tenants	12,900	2,348
Proceeds from sale of common shares, net of offering costs	779,241	61,682
Payment of debt refinancing, deferred financing costs, and other financing activities	(18,479)	(6,687)
Net cash provided by financing activities	1,785,191	835,219
Increase (decrease) in cash, cash equivalents, and restricted cash for period	192,361	(952,656)
Effect of exchange rate changes	4,356	(9,157)
Cash, cash equivalents, and restricted cash at beginning of period	556,369	1,467,991
Cash, cash equivalents, and restricted cash at end of period	753,086	506,178
Interest paid	82,471	80,721
Supplemental schedule of non-cash financing activities:
Dividend / Distributions declared, unpaid	163,443	141,667
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	549,884	1,462,286
Restricted cash, included in Other assets at beginning of period	$ 6,485	$ 5,705
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	us-gaap:OtherAssets	us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at beginning of period	$ 556,369	$ 1,467,991
Cash and cash equivalents at end of period	746,753	500,213
Restricted cash, included in Other assets at end of period	$ 6,333	$ 5,965
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	us-gaap:OtherAssets	us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at end of period	$ 753,086	$ 506,178
MPT Operating Partnership, L.P. [Member]
Operating activities
Net income	163,880	81,157
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	78,606	63,833
Amortization of deferred financing costs and debt discount	3,817	3,210
Straight-line rent revenue and other	(65,333)	(47,846)
Share / (Unit)-based compensation expense	12,264	10,036
Gain from sale of real estate	(989)	(1,325)
Impairment charges		19,006
Straight-line rent and other (recovery) write-off	(5,238)	7,717
Debt refinancing and unutilized financing costs	2,269	611
Pre-acquisition rent collected - Circle Transaction		(35,020)
Other adjustments	(3,575)	(421)
Changes in:
Interest and rent receivables	13,396	2,137
Accounts payable and accrued expenses	5,062	(4,221)
Deferred revenue	(15,429)	8,040
Net cash provided by operating activities	188,730	106,914
Investing activities
Cash paid for acquisitions and other related investments	(1,778,417)	(1,973,661)
Net proceeds from sale of real estate	10,905	9,597
Principal received on loans receivable	40,937
Investment in loans receivable	(23,935)	(2,307)
Return of equity investment	11,000	63,122
Capital additions and other investments, net	(42,050)	8,460
Net cash used for investing activities	(1,781,560)	(1,894,789)
Financing activities
Proceeds from term debt, net of discount	1,839,735	915,950
Payments of term debt	(689,450)
Revolving credit facilities, net	8,910
Dividends / Distribution paid	(147,666)	(138,074)
Lease deposits and other obligations to tenants	12,900	2,348
Proceeds from sale of units, net of offering costs	779,241	61,682
Payment of debt refinancing, deferred financing costs, and other financing activities	(18,479)	(6,687)
Net cash provided by financing activities	1,785,191	835,219
Increase (decrease) in cash, cash equivalents, and restricted cash for period	192,361	(952,656)
Effect of exchange rate changes	4,356	(9,157)
Cash, cash equivalents, and restricted cash at beginning of period	556,369	1,467,991
Cash, cash equivalents, and restricted cash at end of period	753,086	506,178
Interest paid	82,471	80,721
Supplemental schedule of non-cash financing activities:
Dividend / Distributions declared, unpaid	163,443	141,667
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	549,884	1,462,286
Restricted cash, included in Other assets at beginning of period	$ 6,485	$ 5,705
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	us-gaap:OtherAssets	us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at beginning of period	$ 556,369	$ 1,467,991
Cash and cash equivalents at end of period	746,753	500,213
Restricted cash, included in Other assets at end of period	$ 6,333	$ 5,965
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	us-gaap:OtherAssets	us-gaap:OtherAssets
Cash, cash equivalents, and restricted cash at end of period	$ 753,086	$ 506,178